These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6866409)

  • 1. [Outcomes and prognosis of uveal melanoblastomas following different variants of combined treatment].
    Kotelianskiĭ EO; Zaslavskaia AM
    Oftalmol Zh; 1983; 38(1):9-12. PubMed ID: 6866409
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
    Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic role of morphological characteristics of the immune response in uveal melanoblastomas of various cellular types].
    Vit VV
    Arkh Patol; 1983; 45(7):25-30. PubMed ID: 6625934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors of extraocular spread after local treatment of uveal melanoma].
    Neroev VV; Saakian SV; Amirian AG; Val'skiĭ VV
    Vestn Oftalmol; 2011; 127(2):21-5. PubMed ID: 21721267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
    Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
    Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after primary enucleation of largest uveal melanomas.
    Gambrelle J; Kodjikian L; Grange JD
    Acta Ophthalmol Scand; 2005 Jun; 83(3):398; 398-9. PubMed ID: 15948802
    [No Abstract]   [Full Text] [Related]  

  • 7. A prognostic model and staging for metastatic uveal melanoma.
    Eskelin S; Pyrhönen S; Hahka-Kemppinen M; Tuomaala S; Kivelä T
    Cancer; 2003 Jan; 97(2):465-75. PubMed ID: 12518371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hierarchization of the prognostic factors in uveal malignant melanoma].
    Călugăru M; Mera M; Călugăru D
    Oftalmologia; 2000; 50(1):30-4. PubMed ID: 11021104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variates of survival in metastatic uveal melanoma.
    Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
    J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The morphological forms of malignant uveal melanoma].
    Simionescu C
    Oftalmologia; 1993; 37(1):3-11. PubMed ID: 8507607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
    Tóth-Molnár E; Hammer H; Oláh J
    Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apropos of 371 cases of malignant melanoblastomas of the skin and orifices. Factors of prognosis].
    Dargent M; Colon J; Estigarribia A
    Ann Chir; 1970 Feb; 24(3):151-78. PubMed ID: 5419383
    [No Abstract]   [Full Text] [Related]  

  • 15. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma.
    Schmittel A; Bechrakis NE; Martus P; Mutlu D; Scheibenbogen C; Bornfeld N; Foerster MH; Thiel E; Keilholz U
    Eur J Cancer; 2004 Nov; 40(16):2389-95. PubMed ID: 15519510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management of posterior uveal melanoma.
    Zhao DY; Shields CL; Shields JA; Gunduz K
    J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
    Kleineidam M; Guthoff R
    Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic uveal melanoma.
    Singh AD; Borden EC
    Ophthalmol Clin North Am; 2005 Mar; 18(1):143-50, ix. PubMed ID: 15763199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.